Description: Recordati Industria Chimica e Farmaceutica S.p.A., together with its subsidiaries, engages in the research, development, manufacture, marketing, and sale of pharmaceuticals worldwide. The company offers pharmaceuticals in various therapeutic areas, including cardiovascular, dermatology, over the counter/non-prescription pharmaceuticals, urology, anti-infectives, central nervous system, gastrointestinal, gynecology and obstetrics, musculo-skeletal disorders and analgesia, nutrition and related products, cosmetics, dietary supplements, medical devices, allergy, endocrinology, respiratory, pain management/inflammation, generics, antipyretics and cold preparations, and oncology, as well as ear, nose, and throat. It also provides products for rare diseases; and pharmaceutical chemicals, such as chemical syntheses, active pharmaceutical ingredients, and intermediates. The company was founded in 1926 and is headquartered in Milan, Italy. Recordati Industria Chimica e Farmaceutica S.p.A. operates as a subsidiary of Rossini S.à R.L.
Home Page: www.recordati.com
1, Via Matteo Civitali
Milan,
MI
20148
Italy
Phone:
39 02 487871
Officers
| Name | Title |
|---|---|
| Dr. Robert Koremans M.D. | CEO & Director |
| Ms. Cathrin Petty | Exec. Director |
| Mr. Giampiero Mazza | Exec. Director |
| Mr. Giorgio De Palma | Exec. Director |
| Mr. Luigi Felice La Corte | Group CFO & Exec. Director |
| Ms. Federica De Medici | Director of Investor Relations & Corp. Communications |
| Ms. Daria Ghidoni | Group Gen. Counsel |
| Mr. Giovanni Minora | Group Audit & Compliance |
| Mr. Gabriele Finzi | Exec. VP of Corp. Devel. & Licensing |
| Mr. Giuseppe Gualazzini | Sr. VP of Group HR |
Exchange: MI
Country: IT
Currency: Euro (€)
| Forward PE: | 16.4204 |
|---|---|
| Trailing PE: | 24.9304 |
| Price-to-Book MRQ: | 5.2131 |
| Price-to-Sales TTM: | 4.616 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 4300 |